Orion IV Is a Dedicated Cardiovascular Outcome Trial Um and It's Getting FDA Approved

Pcsk9 inhibitors are approved in you know ascvd patients of patients who have fh as an adjunct to diet and statins for patients that remain with residual elevated LDL. The 50% reduction is actually not i mean it's relatively comparable to a high intensity statin so would you continue a statin and give this to kind of give us on the extra push or just to do instead? I guess how are we using these medications with statin therapy is a question that i hadYeah I think our main role in the near term my ex paul tell me what you're where your head's at with thisi think probably is going to be identifying who might benefit in referring to